Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of D797 on Pharmacokinetics of D324 in Healthy Volunteers

Trial Profile

A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of D797 on Pharmacokinetics of D324 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs Donepezil (Primary) ; Memantine (Primary)
  • Indications Alzheimer's disease; Cognition disorders; Dementia; Down syndrome; Lewy body disease; Vascular dementia
  • Focus Pharmacokinetics
  • Acronyms CKD-355 DDI P1
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 29 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top